Prolonged NOACs beat warfarin for lowering recurrent VTE risk: study
Patients prescribed extended anticoagulation for VTE have a lower risk of recurrent VTE with NOACs compared to warfarin, according to a study in JAMA Network…
Patients prescribed extended anticoagulation for VTE have a lower risk of recurrent VTE with NOACs compared to warfarin, according to a study in JAMA Network…
The medicines watchdog has slapped safety warnings on all oral anticoagulants following post-marketing reports of anticoagulant-related nephropathy presenting as acute kidney injury. On Thursday, the…
Earl is an 88-year-old retired teacher who presents to his GP with gross swelling of the left upper limb for the past 24 hours. The…
Australian study shows AF patients on NOACs are less likely to experience cognitive decline than those on warfarin.
US researchers find three risk factors are linked to an increased risk of VTE after discharge.
Aus researchers say their study has set the scene for a randomised controlled trial that could change practice
Mitchell, a 43-year-old labourer, presents with 48 hours of worsening ache in the left lower back, hip and posterior thigh, as well as left leg wea…
A young recreational sports player presents with a three-week history of vague right shoulder pain.
The first meta-analysis appraising long-term renal outcomes show NOACs are superior to warfarin for patients with non-valvular AF.
A discharge medicine was accidentally prescribed as an inpatient medicine.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.